Systematix retains Buy on Tata Capital, sets ₹400 target
Systematix sees scope for Tata Capital’s valuation discount to narrow, citing growth, margin improvement and stable asset quality. Risks include RBI flexi-loan rules, funding costs, crude-led growth pressure and potential asset-quality deterioration.
What happened
Systematix retained a Buy on Tata Capital with a Rs 400 12-month target, citing growth, margin improvement and stable asset quality. It sees valuation-discount
Key facts
- 45% above Street estimates
- 32% discount to CIFC on FY28 BVPS
- Flexi/revolving products are 8-9% of overall loan book
- Less than 5% of flexi exposure is true revolving credit
- LAS and supply-chain financing account for around 95% of flexi exposure
- 2.7x FY28E PABV
- Rs 400 per share target price
Why this matters
Tata Capital’s anticipated valuation rerating strengthens its position as a potential strategic financing partner, while regulatory and funding-cost risks should shape deal diligence.
What to watch
- Quarterly margin expansion despite funding-cost pressure.
- Loan growth remains above industry growth without a rise in early-bucket delinquencies.
- Credit costs stay within or below guidance and GNPA/NNPA remain stable.
- RBI rules materially restrict flexi-loan sourcing, tenor structures or capital treatment.
- A sustained crude-price spike weakens consumption, inflation and borrower repayment capacity.
- Funding spreads widen or rating outlooks change for NBFC issuers.
- Material deviation from the implied FY28 book-value and profitability path underpinning the ₹400 target.
- Track quarterly loan-book growth by retail, SME and corporate segments versus management guidance and major NBFC peers.
- Monitor net interest margin, cost of funds and the mix of bank borrowing, market debt and deposits/fixed deposits where applicable.
- Assess RBI communications and implementation details on flexi-loan and unsecured-credit rules for product-level growth implications.
- Watch gross and net NPAs, early-stage delinquencies, restructured exposures and credit-cost guidance for signs of asset-quality normalization or stress.
- Compare the stock's price-to-book valuation and return-on-equity trajectory with leading diversified NBFC peers, especially CIFC.
- Follow crude prices, rural demand indicators, consumer spending and SME repayment data as leading signals for credit demand and defaults.